Carla Talarico, PhD, MPH (she/her/hers)

Director
Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA

Disclosure(s): AstraZeneca: Employee of AstraZeneca and may hold stock and/or stock options

Poster(s):

• (P-418) A Need for Infection Prevention among Patients with ESKD on Maintenance Dialysis: a First Step in Understanding how SARS-CoV-2 Impacts this Population
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-1989) COVID-19 Mortality Among Immunocompromised Individuals is Consistently High Compared with Non-Immunocompromised Individuals: Results of the INFORM Study 2022, England
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT

• (P-2006) Individuals on Immunosuppressive or Immunomodulatory Therapies Remain at Increased Risk of COVID-19 Hospitalization, Despite Vaccination: Findings from INFORM, a Retrospective Health Database Study in England
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT